Skip to main content
メニュー
JP

VesselVue Microbubble Contrast Agent

Visualize microvasculature

Revvity’s VesselVue™ microbubble contrast agent is a lipid encapsulated micron-sized particle with a gas core that are injected intravenously into the animal. This agent is non-toxic to the animal, and with each microbubble being smaller than a red blood cell, circulate systemically and clear the body in minutes.

Contrast-enhanced ultrasound (CEUS) is a technique that uses microbubble-based contrast agents to improve the echogenicity of blood which in turn enhances and aids in the visualization of vessels and tissue vascularity.

VesselVue microbubble contrast agent can be used to study tissue perfusion and blood flow characteristics on ultrasound systems equipped with CEUS imaging modes. Using VesselVue in combination with our exclusive Acoustic Angiography mode on the Vega® ultrasound system, a unique form of CEUS imaging, researchers can obtain high resolution images of microvessel density and morphology, which are biomarkers useful for studying angiogenesis and vascular bed development.

For research use only. Not for use in therapeutic or diagnostic procedures.
 


VesselVue microbubble contrast agent is available in a P-formulation for your research

P-formulation-histogram-illustration.jpg

Wide microbubble size distribution with a smaller mean.


Structure of vesselVue microbubble contrast agent

Activation is required for VesselVue P-formulation.

Microbubbles-added-P-formulation.jpg

(Left) Activation of VesselVue P-formulation microbubble contrast agents pre and post mechanical agitation using a VesselVue Microbubble Mixer (sold separately). (Right) Structure of microbubbles.
 

Kidney-Vasculature.jpg


Kidney (left) and Tumor (right) vascularity using VesselVue microbubble contrast agent and acoustic angiography using the Vega ultrasound imaging system.

Visualize and quantify vascular network architecture and density of tumors or organs over time

  • Evaluate tumor angiogenesis
  • Explore response to therapy prior to tissue changes
  • Collect high-resolution images of 3D microvessel trees in minutes and 2D capture in less than a second (using the Vega® ultrasound system)
  • Polydisperse formulation for general CEUS imaging applications
VesselVue Microbubble Contrast Agent
bg-element-listing-page bg-element-listing-page-mobile
Products & Services
Resource Library
Filters
Expand All|Collapse All
Product Type
Application
Brand
Sort by: Recommended
Recommended
Product Name A-Z
Product Name Z-A
1 - 1 of 1 Products and Services
VesselVue® microbubble contrast agent, P-formulation

VesselVue™ P-formulation microbubble contrast agent designed for contrast enhanced ultrasound (CEUS), is a polydisperse diameter distribution that is ideal for a wide-range of vascular ultrasound imaging applications and exploratory studies. For research use only. Not for use in therapeutic or diagnostic procedures.

Part Number: P-4007003
Filters
Expand All|Collapse All
Resource Type
Sort by: Resource Name A-Z
Resource Name A-Z
Resource Name Z-A
1 - 3 of 3 Resources
Case Study
Case Study
Assessing murine glioblastoma growth: a comparative study of ultrasound and MRI imaging modalities

Researchers at the University of North Carolina use automated, high throughput ultrasound and acoustic angiography as an alternative to MRI for tracking glioblastoma in mice. These results highlight the potential of ultrasound imaging using the Vega ™ for tracking tumor progression particularly in later stages when tumors are more easily detectable. Furthermore, these findings suggest that the Vega system could be used in drug discovery research to prioritize compounds for further evaluation before committing to MRI, which is more time-consuming and expensive.

Datasheet
Datasheet
Bead Ruptor VesselVue Homogenizer Datasheet

The Bead Rupture™ VesselVue™ Homogenizer is the device used to activate VesselVue P-formulation microbubble contrast agent

eBook
eBook
In vivo imaging solutions

Researchers trust our in vivo imaging solutions to give them reliable, calibrated data that reveals pathway characterization and therapeutic efficacies for a broad range of indications. Our reagents, instruments, and applications support have helped hundreds of research projects over the years. And our hard-earned expertise makes us a trusted provider of pre-clinical imaging solutions— with more than 20,000 peer reviewed articles as proof.